Your session is about to expire
← Back to Search
Standard Care + Photodynamic Therapy for Brain Tumor
Study Summary
This trial is studying adding photodynamic therapy to surgery, radiation therapy, and chemotherapy in treating patients with newly diagnosed or recurrent malignant supratentorial gliomas.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- My scans show I can have surgery to remove my cancer completely.I have not had brain radiation for my new tumor.My brain tumor is classified as a high-grade astrocytoma.My creatinine levels are 2 mg/dL or lower.I am 18 years old or older.My liver function tests are within the required limits.My brain tumor is confirmed as glioblastoma or malignant astrocytoma.My cancer came back after both surgery and radiation failed.I can care for myself but may not be able to do active work (new diagnosis) or I am able to care for myself and do light to normal activity (recurrent).
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new patients currently being accepted into this clinical trial?
"According to the information available on clinicaltrials.gov, this study is not looking for new participants at this time. This particular trial was posted on April 1st, 1998 and last updated November 5th, 2013. There are other 116 trials that are currently searching for patients."
Are there different research facilities working on this project?
"Currently, 4 different medical centres are enrolling patients for this clinical trial. These locations include Toronto, Englewood and Buffalo among others. If you are interested in participating, please select the location nearest to you to reduce travel burdens."
Could you please list the risks associated with this treatment?
"The safety of this Phase 3 trial medication has been estimated to be a 3."
Share this study with friends
Copy Link
Messenger